Ledger.Open graph →
SEC Form D · Amendment · filed August 17, 2016

Bioniz Therapeutics, Inc

Offering
$15.0M
Sold
$10.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
IRVINE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Joe Kiani · Irvine, CADirectorDavid E. Pyott · Irvine, CADirectorIlan Zipkin · Irvine, CADirectorNazli Azimi · Irvine, CAExec · DirectorHenry M. Lomax · Charlotte, NCExec · DirectorDavid Hulshof · Leawood, KSDirectorRichard C. Rizzuto · Highlands Ranch, CODirectorDouglas C. Gordon · Highlands Ranch, CODirectorBarry Funt · New York, NYExec · DirectorCharles P. Keates · Newtown Square, PADirectorMelissa T. Heim · Portland, ORDirectorMichael R. Markunas · Los Angeles, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗